NABI /DE/
424B3, 1996-11-15
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NEW YORK STATE ELECTRIC & GAS CORP, S-8, 1996-11-15
Next: NABI /DE/, 424B3, 1996-11-15



<PAGE>
 
PROSPECTUS SUPPLEMENT                          Filed pursuant to Rule 424(b)(3)
To Prospectus Dated May 3, 1996,                      Registration No. 333-2253 
As Supplemented to Date                         

                                  $80,500,000

                                     NABI

                6 1/2% Convertible Subordinated Notes due 2003

                                      and

               Shares of Common Stock, Par Value $.10 Per Share,
                       Issuable Upon Conversion Thereof

        This Prospectus Supplement (the "Supplement") relates to the resale by 
Raymond James & Associates, Inc. ("Raymond James") of up to $15,000 aggregate 
principal amount of 6 1/2% Convertible Subordinated Notes due 2003 (the "Notes")
of NABI, a Delaware corporation (the "Company"), originally issued in private 
placements consummated on February 7 and March 6, 1996 (the "Debt Offering"), 
pursuant to NABI's Registration Statement on Form S-3 (No. 333-2253) (the 
"Registration Statement"). This Supplement should be read in conjunction with 
the Prospectus dated May 3, 1996, as supplemented to date (the "Prospectus"), to
be delivered with this Supplement. All capitalized terms used but not defined in
this Supplement shall have the meanings given them in the Prospectus.

        Based on information provided to the Company, the aggregate principal 
amount of the Notes that are currently beneficially owned by Raymond James is 
$555,000, of which $15,000 may be sold at this time pursuant to the Prospectus 
as supplemented hereby. Raymond James was an initial purchaser of the Notes in 
the Debt Offering and also was the managing underwriter in the Company's 
October 1994 public offering of 4,200,000 shares of Common Stock. In connection 
with both such offerings, Raymond James received customary compensation for its 
services. Additional information concerning the Selling Securityholders 
(including Raymond James) may be set forth from time to time in additional 
supplements to the Prospectus. The total outstanding aggregate principal amount 
of the Notes is $80,500,000.

        The closing price of the Company's Common Stock as reported on The 
Nasdaq National Market on November 13, 1996 was $7.75 per share.

        The Notes will be subordinated to all existing and future Senior 
Indebtedness of the Company. At August 23, 1996, Senior Indebtedness was 
approximately $6,300,000. The Indenture contains no limitations on the 
incurrence of additional indebtedness or other liabilities by the Company.

        The Notes are neither listed on a national securities exchange nor 
quoted on an automated quotation system. However, the Notes are eligible for 
trading in the Private Offerings, Resales and Trading through Automated Linkages
("PORTAL") Market. Notes sold pursuant to the Registration Statement will no 
longer be eligible for trading in the PORTAL Market.

        The date of this Prospectus Supplement is November 14, 1996.
<PAGE>
 
PROSPECTUS SUPPLEMENT                           Filed pursuant to Rule 424(b)(3)
To Prospectus Dated May 3, 1996,                       Registration No. 333-2253
As Supplemented to Date 

                                  $80,500,000

                                     NABI

                6 1/2% Convertible Subordinated Notes due 2003
                                      and
               Shares of Common Stock, Par Value $.10 Per Share,
                       Issuable Upon Conversion Thereof

      This Prospectus Supplement (the "Supplement") relates to the resale by 
Forum Capital Markets L.P. ("Forum") of up to $500,000 aggregate principal 
amount of 6 1/2% Convertible Subordinated Notes due 2003 (the "Notes") of NABI, 
a Delaware corporation (the "Company"), originally issued in private placements 
consummated on February 7 and March 6, 1996 (the "Debt Offering"), pursuant to 
NABI's Registration Statement on Form S-3 (No. 333-2253) (the "Registration 
Statement"). This Supplement should be read in conjunction with the Prospectus 
dated May 3, 1996, as supplemented to date (the "Prospectus"), to be delivered 
with this Supplement. All capitalized terms used but not defined in this 
Supplement shall have the meanings given them in the Prospectus.

      Based on information provided to the Company, the aggregate principal 
amount of the Notes that are currently beneficially owned by Forum is $500,000, 
all of which may be sold at this time pursuant to the Prospectus as supplemented
hereby. Additional information concerning the Selling Securityholders (including
Forum) may be set forth from time to time in additional supplements to the 
Prospectus. The total outstanding aggregate principal amount of the Notes is 
$80,500,000.

      The closing price of the Company's Common Stock as reported on The Nasdaq 
National Market on November 12, 1996 was $8.125 per share.

      The Notes will be subordinated to all existing and future Senior 
Indebtedness of the Company. At August 23, 1996, Senior Indebtedness was 
approximately $6,300,000. The Indenture contains no limitations on the 
incurrence of additional indebtedness or other liabilities by the Company.

      The Notes are neither listed on a national securities exchange nor quoted 
on an automated quotation system. However, the Notes are eligible for trading in
the Private Offerings, Resales and Trading through Automated Linkages ("PORTAL")
Market. Notes sold pursuant to the Registration Statement will no longer be 
eligible for trading in the PORTAL Market.

         The date of this Prospectus Supplement is November 13, 1996.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission